Jubilant Pharmova Limited reported earnings results for the full year ended March 31, 2024. For the full year, the company reported sales was INR 66,448 million compared to INR 62,193 million a year ago. Revenue was INR 67,716 million compared to INR 63,200 million a year ago.

Net income was INR 771 million compared to net loss of INR 610 million a year ago. Basic earnings per share from continuing operations was INR 4.87 compared to basic loss per share from continuing operations of INR 3.83 a year ago. Diluted earnings per share from continuing operations was INR 4.86 compared to diluted loss per share from continuing operations of INR 3.83 a year ago.